[{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++IM01-12 Vaccines (oncolytic and prophylactic),,"},{"Key":"Keywords","Value":"KRAS,Vaccines,KRAS mutation,mRNA,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>Chang Gyu Lim<\/b><sup><\/sup>, Seung-Hyun Shin<sup><\/sup>, Youngjin Han<sup><\/sup>, Yong Ho Heo<sup><\/sup>, Innah Kim<sup><\/sup>, Ji Hee Lee<sup><\/sup>, Miyoung Lee<sup><\/sup>, Seongju Jeong<sup><\/sup>, Yunjae Kim<sup><\/sup>, Jooyun Byun<sup><\/sup>, Daejin Kim<sup><\/sup>, In Young Choi<sup><\/sup><br><br\/>Hanmi Pharmaceutical Co., Ltd., Seoul, Korea, Republic of","CSlideId":"","ControlKey":"59c41f40-2c4d-49db-8bb7-5210bdef06f6","ControlNumber":"10341","DisclosureBlock":"<b>&nbsp;C. Lim, <\/b> <br><b>Hanmi Pharmaceutical Co., Ltd.<\/b> Employment. <br><b>S. Shin, <\/b> <br><b>Hanmi Pharmaceutical Co., Ltd.<\/b> Employment. <br><b>Y. Han, <\/b> <br><b>Hanmi Pharmaceutical Co., Ltd.<\/b> Employment. <br><b>Y. Heo, <\/b> <br><b>Hanmi Pharmaceutical Co., Ltd.<\/b> Employment. <br><b>I. Kim, <\/b> <br><b>Hanmi Pharmaceutical Co., Ltd.<\/b> Employment. <br><b>J. Lee, <\/b> <br><b>Hanmi Pharmaceutical Co., Ltd.<\/b> Employment. <br><b>M. Lee, <\/b> <br><b>Hanmi Pharmaceutical Co., Ltd.<\/b> Employment. <br><b>S. Jeong, <\/b> <br><b>Hanmi Pharmaceutical Co., Ltd.<\/b> Employment. <br><b>Y. Kim, <\/b> <br><b>Hanmi Pharmaceutical Co., Ltd.<\/b> Employment. <br><b>J. Byun, <\/b> <br><b>Hanmi Pharmaceutical Co., Ltd.<\/b> Employment. <br><b>D. Kim, <\/b> <br><b>Hanmi Pharmaceutical Co., Ltd.<\/b> Employment. <br><b>I. Choi, <\/b> <br><b>Hanmi Pharmaceutical Co., Ltd.<\/b> Employment.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10598","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"1","PosterboardNumber":"1","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB352","PresenterBiography":null,"PresenterDisplayName":"Chang Gyu Lim, MS","PresenterKey":"8b298538-0019-473c-a455-71256b85086e","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB352. Unraveling therapeutic potentials of mRNA-based cancer vaccine concurrently targeting heterogeneous KRAS mutant cancer","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"603","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Immunology 3","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Unraveling therapeutic potentials of mRNA-based cancer vaccine concurrently targeting heterogeneous KRAS mutant cancer","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++IM01-12 Vaccines (oncolytic and prophylactic),,"},{"Key":"Keywords","Value":"Microenvironment,Interferons,Vaccines,Immunogenic cell death,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"N. Cuburu, S. K. Sethi, C. E. Bradley, L. Bialkowski, C. D. Thompson, D. R. Lowy, <b>J. T. Schiller<\/b>; <br\/>National Cancer Institute, Bethesda, MD","CSlideId":"","ControlKey":"77a89299-ff63-4386-b25e-df910abd4420","ControlNumber":"9752","DisclosureBlock":"&nbsp;<b>N. Cuburu, <\/b> None..<br><b>S. K. Sethi, <\/b> None..<br><b>C. E. Bradley, <\/b> None..<br><b>L. Bialkowski, <\/b> None..<br><b>C. D. Thompson, <\/b> None..<br><b>D. R. Lowy, <\/b> None..<br><b>J. T. Schiller, <\/b> None.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10599","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"2","PosterboardNumber":"2","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB353","PresenterBiography":null,"PresenterDisplayName":"John Schiller, PhD","PresenterKey":"5f2d5ff6-d985-4b44-b43f-37083c308f4a","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB353. Repurposing varicella zoster virus and human papillomavirus vaccines for local immunotherapy against solid tumors","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"603","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Immunology 3","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Repurposing varicella zoster virus and human papillomavirus vaccines for local immunotherapy against solid tumors","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++IM01-12 Vaccines (oncolytic and prophylactic),,"},{"Key":"Keywords","Value":"Oncolytic virus,Multiple systemic administration,Anti-tumor efficacy,Neutralization evasion,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>Y. Yang<\/b><sup>1<\/sup>, S. Won<sup>1<\/sup>, N. Lee<sup>2<\/sup>, E. Kim<sup>1<\/sup>, S. Lee<sup>2<\/sup>, M.-J. Park<sup>2<\/sup>, B.-J. Jung<sup>2<\/sup>, Y.-K. Hong<sup>2<\/sup>, H.-R. Kim<sup>1<\/sup>, D.-S. Lee<sup>1<\/sup>, K. Oh<sup>2<\/sup>; <br\/><sup>1<\/sup>Seoul National University, College of Medicine, Seoul, Korea, Republic of, <sup>2<\/sup>SillaJen, Inc., Yongin, Korea, Republic of","CSlideId":"","ControlKey":"08b8b1d9-1ef0-460a-bfb2-9dc9bc178114","ControlNumber":"9908","DisclosureBlock":"&nbsp;<b>Y. Yang, <\/b> None..<br><b>S. Won, <\/b> None..<br><b>N. Lee, <\/b> None..<br><b>E. Kim, <\/b> None..<br><b>S. Lee, <\/b> None..<br><b>M. Park, <\/b> None..<br><b>B. Jung, <\/b> None..<br><b>Y. Hong, <\/b> None..<br><b>H. Kim, <\/b> None..<br><b>D. Lee, <\/b> None..<br><b>K. Oh, <\/b> None.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10600","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"3","PosterboardNumber":"3","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB354","PresenterBiography":null,"PresenterDisplayName":"Yeonsoo Yang","PresenterKey":"c8ce8db1-a047-4347-a084-a3d7c272fbe4","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB354. A novel oncolytic vaccinia virus with intravenous compatibility evaded complement- and neutralizing antibody-mediated inhibition and provided superior anti-tumor activity to intra-tumoral administration in immunocompetent mice","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"603","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Immunology 3","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"A novel oncolytic vaccinia virus with intravenous compatibility evaded complement- and neutralizing antibody-mediated inhibition and provided superior anti-tumor activity to intra-tumoral administration in immunocompetent mice","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++IM01-12 Vaccines (oncolytic and prophylactic),,"},{"Key":"Keywords","Value":"Immune checkpoint blockade,Immunotherapy,Cancer vaccine,Cryotherapy,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"J. B. DuHadaway<sup>1<\/sup>, A. J. Muller<sup>1<\/sup>, L. D. Laury-Kleintop<sup>1<\/sup>, U. Wallon<sup>1<\/sup>, S. K. Gilmour<sup>1<\/sup>, M. Webster<sup>1<\/sup>, J. R. Williams<sup>2<\/sup>, G. R. Rossi<sup>3<\/sup>, M. R. Mautino<sup>3<\/sup>, J. Lewis<sup>3<\/sup>, C. J. Link<sup>3<\/sup>, <b>G. C. Prendergast<\/b><sup>1<\/sup>; <br\/><sup>1<\/sup>Lankenau Institute for Medical Research (LIMR), Wynnewood, PA, <sup>2<\/sup>Williams Cancer Institute, Beverly Hills, CA, <sup>3<\/sup>Syncromune, Inc., Fort Lauderdale, FL","CSlideId":"","ControlKey":"7856202d-d6fc-4ca9-aa61-9cf51a96ed4b","ControlNumber":"10795","DisclosureBlock":"&nbsp;<b>J. B. DuHadaway, <\/b> None.&nbsp;<br><b>A. J. Muller, <\/b> <br><b>IO Biotech<\/b> Independent Contractor, Stock, Stock Option, Grant\/Contract. <br><b>Augen Therapeutics, Inc.<\/b> Stock, Stock Option, Patent, Other, Scientific Advisor. <br><b>L. D. Laury-Kleintop, <\/b> <br><b>Augen Therapeutics, Inc.<\/b> Independent Contractor, Stock Option, Patent, Other, Scientific Advisor. <br><b>U. Wallon, <\/b> <br><b>Mynari Biomedical, Inc.<\/b> Patent.<br><b>S. K. Gilmour, <\/b> None..<br><b>M. Webster, <\/b> None.&nbsp;<br><b>J. R. Williams, <\/b> <br><b>Syncromune, Inc.<\/b> Independent Contractor, Stock, Stock Option, Patent. <br><b>G. R. Rossi, <\/b> <br><b>Syncromune, Inc.<\/b> Employment. <br><b>M. R. Mautino, <\/b> <br><b>Syncromune, Inc.<\/b> Employment. <br><b>J. Lewis, <\/b> <br><b>Syncromune, Inc.<\/b> Employment. <br><b>C. J. Link, <\/b> <br><b>Syncromune, Inc.<\/b> Employment. <br><b>G. C. Prendergast, <\/b> <br><b>Immunome, Inc.<\/b> Independent Contractor, Stock, Other, Scientific Advisor. <br><b>Merck, Inc.<\/b> Stock. <br><b>Augen Therapeutics, Inc.<\/b> Fiduciary Officer, Stock Option, Travel, Patent. <br><b>Dynamis Therapeutics, Inc.<\/b> Stock Option, Patent, Other, Scientific Advisor. <br><b>MBF Therapeutics, Inc.<\/b> Stock. <br><b>Meditope Biosciences, Inc.<\/b> Fiduciary Officer, Stock, Stock Option. <br><b>Ribonova, Inc.<\/b> Independent Contractor, Stock, Other, Scientific Advisor. <br><b>Syncromune, Inc.<\/b> Independent Contractor, Stock, Stock Option, Other, Scientific Advisor.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10601","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"4","PosterboardNumber":"4","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB355","PresenterBiography":null,"PresenterDisplayName":"George Prendergast, PhD","PresenterKey":"86d93c2e-170a-41ae-903f-19925e097680","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB355. Cryo-immune vaccination (CIV) by SYNC-T therapy: Preclinical modeling of a novel device-multidrug immunotherapeutic approach to eradicate advanced metastatic cancers","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"603","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Immunology 3","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Cryo-immune vaccination (CIV) by SYNC-T therapy: Preclinical modeling of a novel device-multidrug immunotherapeutic approach to eradicate advanced metastatic cancers","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++IM02-02 Epigenetic regulation of tumor immunity,,"},{"Key":"Keywords","Value":"Stemness,Immune response,Epigenetics,Transcriptional regulation,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>D. Avram<\/b>, T. Shaw, S. Pilon-Thomas, L. Silvane, T. Zelenka; <br\/>Moffitt Cancer Center, Tampa, FL","CSlideId":"","ControlKey":"bd236cca-0a01-4232-8373-e49e222150b7","ControlNumber":"9782","DisclosureBlock":"&nbsp;<b>D. Avram, <\/b> None..<br><b>T. Shaw, <\/b> None..<br><b>S. Pilon-Thomas, <\/b> None..<br><b>L. Silvane, <\/b> None..<br><b>T. Zelenka, <\/b> None.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10604","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"5","PosterboardNumber":"7","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB358","PresenterBiography":null,"PresenterDisplayName":"Dorina Avram, PhD","PresenterKey":"964d45d7-b2aa-49bc-9181-50b43dd3234d","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB358. Program and epigenetic control of stemness and exhaustion of tumor infiltrating CD8<sup>+<\/sup> T lymphocytes","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"603","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Immunology 3","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Program and epigenetic control of stemness and exhaustion of tumor infiltrating CD8<sup>+<\/sup> T lymphocytes","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++IM02-04 Inflammation and cancer: Tumor initiation and progression,,"},{"Key":"Keywords","Value":"KRAS,Interleukin-1,Lung cancer: non-small cell,Angiogenesis,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>A. Krishna<\/b><sup>1<\/sup>, M. J. Clowers<sup>1<\/sup>, B. Yuan<sup>2<\/sup>, V. Ha<sup>2<\/sup>, K. Larsen<sup>2<\/sup>, N. Karimi<sup>2<\/sup>, A. Gaitonde<sup>2<\/sup>, J. Colunga<sup>1<\/sup>, M. T. Grimaldo<sup>1<\/sup>, M. J. Arredondo Sancristobal<sup>2<\/sup>, V. Villalba-Sabat<sup>2<\/sup>, A. Baca De Anda<sup>2<\/sup>, Y. Rezai<sup>2<\/sup>, J. Sharma<sup>1<\/sup>, H. Kadara<sup>1<\/sup>, S. Moghaddam<sup>1<\/sup>; <br\/><sup>1<\/sup>The University of Texas MD Anderson Cancer Center UT Health Houston Graduate School of Biomedical Sciences, Houston, TX, <sup>2<\/sup>The University of Texas MD Anderson Cancer Center, Houston, TX","CSlideId":"","ControlKey":"ee75b0a4-c552-4c60-a8d2-8b6d5715253b","ControlNumber":"10579","DisclosureBlock":"&nbsp;<b>A. Krishna, <\/b> None..<br><b>M. J. Clowers, <\/b> None..<br><b>B. Yuan, <\/b> None..<br><b>V. Ha, <\/b> None..<br><b>K. Larsen, <\/b> None..<br><b>N. Karimi, <\/b> None..<br><b>A. Gaitonde, <\/b> None..<br><b>J. Colunga, <\/b> None..<br><b>M. T. Grimaldo, <\/b> None..<br><b>M. J. Arredondo Sancristobal, <\/b> None..<br><b>V. Villalba-Sabat, <\/b> None..<br><b>A. Baca De Anda, <\/b> None..<br><b>Y. Rezai, <\/b> None..<br><b>J. Sharma, <\/b> None..<br><b>H. Kadara, <\/b> None..<br><b>S. Moghaddam, <\/b> None.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10605","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"6","PosterboardNumber":"8","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB359","PresenterBiography":null,"PresenterDisplayName":"Avantika Krishna, BS","PresenterKey":"a03a3f7e-45af-4fcf-8ca3-1d7dc8b09139","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB359. Lung epithelial specific IL-1R promotes K-ras mutant lung cancer by inducing angiogenesis that might be medicated via myeloid tumor microenvironment","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"603","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Immunology 3","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Lung epithelial specific IL-1R promotes K-ras mutant lung cancer by inducing angiogenesis that might be medicated via myeloid tumor microenvironment","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++IM02-04 Inflammation and cancer: Tumor initiation and progression,,"},{"Key":"Keywords","Value":"Biomarkers,RNA editing,Carcinogenesis,Ulcerative colitis,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>T. Takahashi<\/b>, K. Shigeyasu, Y. Kondo, H. Umeda, K. Moriwake, M. Kayano, K. Nitta, F. Teraishi, Y. Umeda, H. Tazawa, T. Fujiwara; <br\/>Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan","CSlideId":"","ControlKey":"65d58970-ee5e-4be7-bbc5-288248962ff9","ControlNumber":"10592","DisclosureBlock":"&nbsp;<b>T. Takahashi, <\/b> None..<br><b>K. Shigeyasu, <\/b> None..<br><b>Y. Kondo, <\/b> None..<br><b>H. Umeda, <\/b> None..<br><b>K. Moriwake, <\/b> None..<br><b>M. Kayano, <\/b> None..<br><b>K. Nitta, <\/b> None..<br><b>F. Teraishi, <\/b> None..<br><b>Y. Umeda, <\/b> None..<br><b>H. Tazawa, <\/b> None..<br><b>T. Fujiwara, <\/b> None.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10606","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"7","PosterboardNumber":"9","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB360","PresenterBiography":null,"PresenterDisplayName":"Toshiaki Takahashi","PresenterKey":"1657d4c0-b98c-4168-a014-0cd944a6e35c","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB360. Establishment of predictive biomarkers for carcinogenesis in ulcerative colitis using RNA editing analyses<b><\/b>","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"603","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Immunology 3","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Establishment of predictive biomarkers for carcinogenesis in ulcerative colitis using RNA editing analyses<b><\/b>","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++IM02-05 Innate immunity to tumors,,"},{"Key":"Keywords","Value":"Innate immunity,Cancer immunotherapy,Interferons,Combination therapy,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>J. Lim<\/b>, R. Rodriguez, K. Williams, J. Silva, A. Gutierrez, P. Tyler, F. Baharom, T. Sun, E. Lin, S. Martin, B. Kayser, R. J. Johnston, I. Mellman, L. Delamarre, N. West, S. Müller, Y. Qu, K. Heger; <br\/>Genentech, Inc., South San Francisco, CA","CSlideId":"","ControlKey":"f70c1ec1-81cc-4b13-b841-199fa19c97cc","ControlNumber":"10807","DisclosureBlock":"<b>&nbsp;J. Lim, <\/b> <br><b>Genentech, Inc.<\/b> Employment. <br><b>R. Rodriguez, <\/b> <br><b>Genentech, Inc.<\/b> Employment. <br><b>K. Williams, <\/b> <br><b>Genentech Inc.<\/b> Employment. <br><b>J. Silva, <\/b> <br><b>Genentech Inc.<\/b> Employment. <br><b>A. Gutierrez, <\/b> <br><b>Genentech, Inc.<\/b> Employment. <br><b>P. Tyler, <\/b> <br><b>Genentech, Inc.<\/b> Employment. <br><b>F. Baharom, <\/b> <br><b>Genentech Inc.<\/b> Employment. <br><b>T. Sun, <\/b> <br><b>Genentech Inc.<\/b> Employment. <br><b>E. Lin, <\/b> <br><b>Genentech Inc.<\/b> Employment. <br><b>S. Martin, <\/b> <br><b>Genentech, Inc.<\/b> Employment. <br><b>B. Kayser, <\/b> <br><b>Genentech, Inc.<\/b> Employment. <br><b>R. J. Johnston, <\/b> <br><b>Genentech, Inc.<\/b> Employment. <br><b>I. Mellman, <\/b> <br><b>Genentech, Inc.<\/b> Employment. <br><b>L. Delamarre, <\/b> <br><b>Genentech Inc.<\/b> Employment. <br><b>N. West, <\/b> <br><b>Genentech, Inc.<\/b> Employment. <br><b>S. Müller, <\/b> <br><b>Genentech, Inc.<\/b> Employment. <br><b>Y. Qu, <\/b> <br><b>Genentech, Inc.<\/b> Employment. <br><b>K. Heger, <\/b> <br><b>Genentech, Inc.<\/b> Employment, Stock, Stock Option.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10607","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"8","PosterboardNumber":"10","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB361","PresenterBiography":null,"PresenterDisplayName":"Junghyun Lim, Unknown","PresenterKey":"c78974df-f97d-4267-b43f-f701671572de","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB361. The exonuclease TREX1 constitutes an innate immune checkpoint limiting cGAS\/STING-mediated anti-tumor immunity","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"603","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Immunology 3","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"The exonuclease TREX1 constitutes an innate immune checkpoint limiting cGAS\/STING-mediated anti-tumor immunity","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++IM02-07 Novel animal models,,"},{"Key":"Keywords","Value":"Animal models,Orthotopic tumor modeling,Clinical relevance,Validation and characterization,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>W. Yang<\/b>, X. Yuan, G. Yang, X. Tong, W. Ding, Q. Zhang, F. Lu, Z. Yang; <br\/>ClinBridge Biotech Co Ltd, Naijing, China","CSlideId":"","ControlKey":"adf95cea-cd57-4b8c-ad69-2fd4eb701722","ControlNumber":"10270","DisclosureBlock":"<b>&nbsp;W. Yang, <\/b> <br><b>ClinBridge Biotech Co Ltd<\/b> Employment. <br><b>X. Yuan, <\/b> <br><b>ClinBridge Biotech Co Ltd<\/b> Employment. <br><b>G. Yang, <\/b> <br><b>ClinBridge Biotech Co Ltd<\/b> Employment. <br><b>X. Tong, <\/b> <br><b>ClinBridge Biotech Co Ltd<\/b> Employment. <br><b>W. Ding, <\/b> <br><b>ClinBridge Biotech Co Ltd<\/b> Employment. <br><b>Q. Zhang, <\/b> <br><b>ClinBridge Biotech Co Ltd<\/b> Employment. <br><b>F. Lu, <\/b> <br><b>ClinBridge Biotech Co Ltd<\/b> Employment. <br><b>Z. Yang, <\/b> <br><b>ClinBridge Biotech Co Ltd<\/b> Employment.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10608","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"9","PosterboardNumber":"11","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB362","PresenterBiography":null,"PresenterDisplayName":"WenQing Yang, PhD","PresenterKey":"39294a74-1d06-4627-8f36-0cb913391ad8","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB362. Systematic development and characterization of orthotopic animal tumor models: A proactive approach to mimic patients' tumor microenvironments for drug discovery","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"603","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Immunology 3","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Systematic development and characterization of orthotopic animal tumor models: A proactive approach to mimic patients' tumor microenvironments for drug discovery","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++IM02-07 Novel animal models,,"},{"Key":"Keywords","Value":"Animal models,Preclinical testing,Natural killer cells,Xenografts,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"Z. Niu<sup>1<\/sup>, Y. Li<sup>1<\/sup>, X. Zhou<sup>1<\/sup>, J. Yao<sup>1<\/sup>, <b>Q. Lin<\/b><sup>2<\/sup>, M. Zhang<sup>1<\/sup>, Q. Xu<sup>1<\/sup>; <br\/><sup>1<\/sup>Biocytogen (Pharmaceuticals) Beijing Co., Beijing, China, <sup>2<\/sup>Biocytogen, Waltham, MA","CSlideId":"","ControlKey":"81d5d079-10cc-4d23-b7ec-e690f638c990","ControlNumber":"10461","DisclosureBlock":"&nbsp;<b>Z. Niu, <\/b> None..<br><b>Y. Li, <\/b> None..<br><b>X. Zhou, <\/b> None..<br><b>J. Yao, <\/b> None..<br><b>Q. Lin, <\/b> None..<br><b>M. Zhang, <\/b> None..<br><b>Q. Xu, <\/b> None.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10609","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"10","PosterboardNumber":"12","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB363","PresenterBiography":"","PresenterDisplayName":"Qingcong Lin, PhD","PresenterKey":"acbdaa49-9fe2-4a5c-85ab-19b084bc2408","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB363. A novel humanized NKP46 mouse model to support xenograft studies evaluating NK cell-based cancer immunotherapies","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"603","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Immunology 3","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"A novel humanized NKP46 mouse model to support xenograft studies evaluating NK cell-based cancer immunotherapies","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++IM02-07 Novel animal models,,"},{"Key":"Keywords","Value":"Natural killer cells,NK humanization in mice,Establishment,Novel animal model,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"F. Lu<sup>1<\/sup>, W. Ding<sup>1<\/sup>, G. Yang<sup>1<\/sup>, Y. Jia<sup>1<\/sup>, Z. Wang<sup>1<\/sup>, X. Yuan<sup>1<\/sup>, M. Yin<sup>2<\/sup>, Z. Yang<sup>1<\/sup>, <b>W. Yang<\/b><sup>1<\/sup>; <br\/><sup>1<\/sup>ClinBridge Biotech Co Ltd, Naijing, China, <sup>2<\/sup>VitalStar Biotech, Beijing, China","CSlideId":"","ControlKey":"52a4d5ef-fe29-46d4-9105-0abcce78295c","ControlNumber":"10505","DisclosureBlock":"<b>&nbsp;F. Lu, <\/b> <br><b>ClinBridge Biotech Co Ltd<\/b> Employment. <br><b>W. Ding, <\/b> <br><b>ClinBridge Biotech Co Ltd<\/b> Employment. <br><b>G. Yang, <\/b> <br><b>ClinBridge Biotech Co Ltd<\/b> Employment. <br><b>Y. Jia, <\/b> <br><b>ClinBridge Biotech Co Ltd<\/b> Employment. <br><b>Z. Wang, <\/b> <br><b>ClinBridge Biotech Co Ltd<\/b> Employment. <br><b>X. Yuan, <\/b> <br><b>ClinBridge Biotech Co Ltd<\/b> Employment. <br><b>M. Yin, <\/b> <br><b>VitalStar Biotech<\/b> Employment. <br><b>Z. Yang, <\/b> <br><b>ClinBridge Biotech Co Ltd<\/b> Employment. <br><b>W. Yang, <\/b> <br><b>ClinBridge Biotech Co Ltd<\/b> Employment.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10610","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"11","PosterboardNumber":"13","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB364","PresenterBiography":null,"PresenterDisplayName":"WenQing Yang, PhD","PresenterKey":"39294a74-1d06-4627-8f36-0cb913391ad8","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB364. Generation and Application of a Robust Humanized Mouse Tumor Model System for Evaluation of NK-Targeting Therapeutics","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"603","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Immunology 3","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Generation and Application of a Robust Humanized Mouse Tumor Model System for Evaluation of NK-Targeting Therapeutics","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++IM02-07 Novel animal models,,"},{"Key":"Keywords","Value":"Xenografts,Animal models,Preclinical testing,Rat,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"Y. Nie<sup>1<\/sup>, M. Zhang<sup>1<\/sup>, W. Zhong<sup>1<\/sup>, J. Feng<sup>1<\/sup>, B. Huwatibieke<sup>1<\/sup>, <b>Z. Yu<\/b><sup>2<\/sup>; <br\/><sup>1<\/sup>Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China, <sup>2<\/sup>Biocytogen, Waltham, MA","CSlideId":"","ControlKey":"de19d0c3-1285-48f4-bf1e-c79834927e82","ControlNumber":"10639","DisclosureBlock":"&nbsp;<b>Y. Nie, <\/b> None..<br><b>M. Zhang, <\/b> None..<br><b>W. Zhong, <\/b> None..<br><b>J. Feng, <\/b> None..<br><b>B. Huwatibieke, <\/b> None..<br><b>Z. Yu, <\/b> None.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10611","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"12","PosterboardNumber":"14","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB365","PresenterBiography":"","PresenterDisplayName":"Qingcong Lin, PhD","PresenterKey":"acbdaa49-9fe2-4a5c-85ab-19b084bc2408","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB365. Generation of a novel severely immunodeficient Sprague Dawley rat model for xenograft studies","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"603","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Immunology 3","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Generation of a novel severely immunodeficient Sprague Dawley rat model for xenograft studies","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++IM02-09 Tumor antigenicity\/processing and presentation,,"},{"Key":"Keywords","Value":"KRAS,Colorectal cancer,Immune checkpoint blockade,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>P. S. Patel<\/b><sup>1<\/sup>, J. Tian<sup>1<\/sup>, F. Fece de la Cruz<sup>1<\/sup>, J. Curtis<sup>1<\/sup>, A. Panda<sup>2<\/sup>, T. Oka<sup>1<\/sup>, S. Demehri<sup>1<\/sup>, M. Sade-Feldman<sup>1<\/sup>, S. Koptez<sup>3<\/sup>, R. B. Corcoran<sup>1<\/sup>; <br\/><sup>1<\/sup>Massachusetts General Hospital Cancer Center, Boston, MA, <sup>2<\/sup>Broad Institute, Cambridge, MA, <sup>3<\/sup>MD Anderson Cancer Center, Houston, TX","CSlideId":"","ControlKey":"415a6f30-3312-494d-8dd4-d22e68f0be80","ControlNumber":"10745","DisclosureBlock":"&nbsp;<b>P. S. Patel, <\/b> None..<br><b>J. Tian, <\/b> None..<br><b>F. Fece de la Cruz, <\/b> None..<br><b>J. Curtis, <\/b> None..<br><b>A. Panda, <\/b> None..<br><b>T. Oka, <\/b> None..<br><b>S. Demehri, <\/b> None..<br><b>M. Sade-Feldman, <\/b> None..<br><b>S. Koptez, <\/b> None..<br><b>R. B. Corcoran, <\/b> None.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10612","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"13","PosterboardNumber":"15","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB366","PresenterBiography":null,"PresenterDisplayName":"Parasvi Patel","PresenterKey":"c820e3ab-595a-497a-aa6e-37390f6f2c5d","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB366. KRAS<sup>G12C<\/sup> inhibition enhances immunogenicity in KRAS<sup>G12C<\/sup>-mutant colorectal cancer","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"603","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Immunology 3","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"KRAS<sup>G12C<\/sup> inhibition enhances immunogenicity in KRAS<sup>G12C<\/sup>-mutant colorectal cancer","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++IM02-09 Tumor antigenicity\/processing and presentation,,"},{"Key":"Keywords","Value":"Antigen presentation,Neoantigens,Immunomodulation,Immune response,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>S. Alvarez Mourid<\/b>, E. James, D. Guglietta, E. Reeves; <br\/>University of Southampton, School of Medicine, Southampton, United Kingdom","CSlideId":"","ControlKey":"245c0084-9859-46d2-b6b8-7637a575eec9","ControlNumber":"10421","DisclosureBlock":"&nbsp;<b>S. Alvarez Mourid, <\/b> None..<br><b>E. James, <\/b> None..<br><b>D. Guglietta, <\/b> None..<br><b>E. Reeves, <\/b> None.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10613","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"14","PosterboardNumber":"16","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB367","PresenterBiography":null,"PresenterDisplayName":"Shami Alvarez Mourid, M Pharm","PresenterKey":"de9f64f1-3540-4a61-ad33-da9f5b73ba95","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB367. Effects of modulation of ERAP1 activity in antigen processing and presentation","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"603","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Immunology 3","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Effects of modulation of ERAP1 activity in antigen processing and presentation","Topics":null,"cSlideId":""}]